Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR

The summary for the Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR: The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia's capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR's 5x3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system's ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation.